SphingoTec

SphingoTec is a privately held German company focused on developing and marketing innovative in-vitro diagnostic (IVD) solutions for novel and proprietary blood-based protein biomarkers. Their mission is to improve patient outcomes with these innovative diagnostic solutions for acute and critical care by providing actionable insights in real time. They specialize in biomarkers for diagnostically underserved acute and critical care conditions such as acute kidney injury (AKI), sepsis, and acute heart failure.

SphingoTec's biomarkers are available as CE IVD microtiter plate assays, a well-established technique suited for laboratories. The company collaborates with internationally leading academic and non-academic medical centers, as well as with global IVD and pharma companies to bring these innovations closer to patients. They are committed to providing products that meet and exceed customer and regulatory requirements, and they manufacture their products in accordance with EN ISO 13485:2016.

SphingoTec is an international, privately held company with a focus on long-term development and a motivating international work environment. They offer rewarding careers for people who embrace their values and want to make the world a healthier place. While specific details regarding job flexibility are not explicitly mentioned, their focus on employee engagement and career development suggests a potential for flexible work arrangements.

SphingoTec offers a variety of benefits to its employees, including competitive compensation, a dynamic working environment in a team that successfully combines experienced industry experts with young high potentials, great career development prospects within an international and innovation-focused company, training and development opportunities, and regular team events.

SphingoTec is a company dedicated to improving patient outcomes in critical care settings by developing innovative diagnostic solutions. They focus on translating scientific advancements into routine clinical practice through novel and proprietary blood-based protein biomarkers, addressing diagnostically underserved conditions like acute kidney injury, sepsis, and acute heart failure. Their goal is to provide clinicians with fast, reliable information to support better patient management and guide treatment strategies.

SphingoTec cultivates a culture of excellence and innovation, characterized by a flat hierarchy and collaborative environment. They value teamwork and appreciate each member's contribution, fostering a sense of shared success and celebrating achievements together. The company embraces a performance-driven approach with a focus on long-term development and growth, emphasizing responsibility and commitment to innovation and change.

SphingoTec emphasizes a culture of excellence and innovation, valuing the diverse perspectives and contributions of its talented team members. The company operates with flat hierarchies, fosters open communication, and offers rewarding careers to individuals who want to improve patient care and make the world a healthier place.